CONTROVERSIAL ASPECTS OF CYTOREDUCTIVE SURGERY IN EPITHELIAL OVARIAN-CANCER

被引：17
作者：
HACKER, NF [1 ]
机构：
[1] ROYAL HOSP WOMEN,GYNAECOL ONCOL,PADDINGTON 2021,AUSTRALIA
来源：
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY | 1989年 / 3卷 / 01期
关键词：
D O I：
10.1016/S0950-3552(89)80041-0
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：49 / 57
页数：9
相关论文
共 30 条
[21]   CHANGING PROGNOSIS AND TREATMENT IN CANCER OF OVARY - A REPORT OF 235 PATIENTS WITH PRIMARY OVARIAN CARCINOMA 1952-1961 [J].
MUNNELL, EW .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1968, 100 (06) :790-&
[22]   RANDOMIZED TRIAL COMPARING 2 COMBINATION CHEMOTHERAPY REGIMENS (CHAP-5 V CP) IN ADVANCED OVARIAN-CARCINOMA [J].
NEIJT, JP ;
TENBOKKELHUININK, WW ;
VANDERBURG, MEL ;
VANOOSTEROM, AT ;
WILLEMSE, PHB ;
HEINTZ, APM ;
VANLENT, M ;
TRIMBOS, JB ;
BOUMA, J ;
VERMORKEN, JB ;
VANHOUWELINGEN, JC .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) :1157-1168
[23]   IMMUNODIAGNOSIS IN OVARIAN-CANCER - BLOCKING FACTOR ACTIVITY [J].
PATTILLO, RA ;
RUCKERT, ACF ;
STORY, MT ;
MATTINGLY, RF .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1979, 133 (07) :791-802
[24]  
SILBERMAN AW, 1982, SURG GYNECOL OBSTET, V155, P577
[25]  
SKIPPER H E, 1964, Cancer Chemother Rep, V35, P1
[26]   THOUGHTS ON CANCER CHEMOTHERAPY AND COMBINATION MODALITY THERAPY (1974) [J].
SKIPPER, HE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (07) :1033-1035
[27]  
TANNOCK I, 1978, CANCER TREAT REP, V62, P1117
[28]  
VANLINDERT ACM, 1984, SURGERY GYNECOLOGICA
[29]  
1987, LANCET, V2, P353
[30]  
1986, GYNECOL ONCOL, V23, P1
123